drugset

drugset / Trial / NCT00758784

Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease

NCT00758784 ↗

Phase 2 Completed 38 enrolled Bausch & Lomb Incorporated

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the safety and efficacy of an ophthalmic solution in dry eye disease.

Timeline

Start: 2008-08-13
Primary completion: 2009-01-14
Completion: 2009-01-14

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bromfenac	Other / unclassified	0.06 %	Other

Indications